Which of the following is the preferred anticoagulant therapy during hemodialysis procedure?
A. Enoxaparin B. Dabigatran C. Rivaroxaban D. Unfractionated heparin(UFH)
Correct Answer: D. Unfractionated heparin (UFH)
Explanation:
Unfractionated heparin (UFH) is the preferred anticoagulant during hemodialysis because it prevents clot formation in the extracorporeal blood circuit and has a rapid onset of action, a short half-life, and can be reversed with protamine sulfate.
Why are the other options incorrect?
- A. Enoxaparin: A low-molecular-weight heparin (LMWH) that is renally cleared and may accumulate in severe renal impairment, increasing bleeding risk.
- B. Dabigatran: A direct thrombin inhibitor primarily used for systemic anticoagulation; it is not routinely used to anticoagulate the hemodialysis circuit.
- C. Rivaroxaban: A direct factor Xa inhibitor used for systemic indications, not routine circuit anticoagulation during hemodialysis.
Exam pearl: UFH is commonly preferred for routine hemodialysis anticoagulation. In patients with active bleeding or a high bleeding risk, heparin-free dialysis or regional citrate anticoagulation may be considered.
57-year-old man with liver cirrhosis and ascites and a Child-Pugh class score of 8 is having severe pain due to injury. What would be the recommended medication?
A. Codeine B. Morphine C. Diclofenac D. Acetaminophen
Correct Answer: D. Acetaminophen (Paracetamol)
Explanation:
In a patient with liver cirrhosis and ascites (Child-Pugh class B, score 8), acetaminophen at a reduced dose is generally the preferred first-line analgesic, even in patients with liver disease.
- A commonly recommended maximum is 2 g/day in cirrhosis, with individualized assessment by the treating clinician.
- Avoid alcohol and combination products containing additional acetaminophen.
- Although the patient reports severe pain, the choice of analgesic should account for hepatic impairment and the risks of alternative agents.
Why are the other options incorrect?
Diclofenac (C - NSAID): Contraindicated. NSAIDs inhibit renal prostaglandins, leading to acute kidney injury (AKI), severe sodium/water retention (worsening ascites), and a significantly increased risk of gastrointestinal bleeding (variceal bleed).
Codeine (A): Avoided. Codeine relies on hepatic metabolism (via CYP2D6) for conversion to its active form (morphine). In impaired liver function, conversion is unpredictable, and opioid clearance is severely reduced, which can precipitate hepatic encephalopathy.
Morphine (B): Use with extreme caution / Second-line. While opioids can be used for severe pain unresponsive to acetaminophen, morphine clearance is markedly impaired in hepatic failure, leading to drug accumulation, profound sedation, respiratory depression, and hepatic encephalopathy. If an opioid is necessary, low doses of short-acting agents are titrated very carefully, but acetaminophen remains the safest baseline medication.
Acetaminophen at reduced dosing is a safe option. In patients with cirrhosis, nonsteroidal anti-inflammatory drugs should be avoided to avert renal failure, and opiates should be avoided or used sparingly, with low and infrequent dosing, to prevent encephalopathy.
Exam pearl: In cirrhosis with ascites, avoid NSAIDs. Acetaminophen up to 2 g/day is generally preferred for routine pain relief; severe acute pain may require carefully selected, closely monitored opioid therapy.
A 68-year-old woman with a history of type-2 diabetes and dyslipidemia is on atenolol and lisinopril. The doctor wants to start statin as her estimated 10-year ASCVD risk is 10%
Which of the following would be the recommended station in (mg)?
A. Atoravastatin 10 (moderate intensity statin)
B. Atoravastatin 40 (HIGH intensity statin)
C. Simvastatin 10(low intensity statin)
D. Simvastatin 80
Correct answer is B. Atorvastatin 40 (HIGH intensity statin).
Explanation:
According to clinical practice guidelines (ACC/AHA and ADA) for primary prevention in patients with diabetes:
Baseline Requirement: All adults aged 40–75 with diabetes mellitus should automatically receive at least a moderate-intensity statin regardless of their calculated baseline risk.
Escalation to High-Intensity Statin: If a patient with diabetes aged 40–75 has a 10-year ASCVD risk of ≥7.5% (or ≥10%), it is recommended to initiate a high-intensity statin to achieve a ≥50% reduction in LDL cholesterol levels.
Since this 68-year-old patient has diabetes and an estimated 10-year ASCVD risk of 10% (which exceeds the threshold), she should be started on a high-intensity statin.
Evaluating the Options:
A. Atorvastatin 10 mg: This is a moderate-intensity statin. While appropriate for diabetes patients with low/standard risk (<7.5%), it is insufficient here due to her elevated 10-year ASCVD risk.
B. Atorvastatin 40 mg: Correct. Atorvastatin 40–80 mg is categorized as a high-intensity statin.
C. Simvastatin 10 mg: This is a low-intensity statin, which is inadequate for diabetes management.
D. Simvastatin 80 mg: This dose is generally not recommended in clinical practice due to a significantly increased risk of severe myopathy/rhabdomyolysis.
Which of the following vaccines is used to prevent cervical cancer ?
A. Zoster B. Varicella C. Human papilloma-virus D. Tetanus, diphtheria, pertussis
Correct Answer: C. Human papillomavirus (HPV) vaccine
Explanation:
The HPV vaccine helps prevent cervical cancer by protecting against high-risk HPV types, particularly HPV-16 and HPV-18, which are responsible for most cases of cervical cancer.
HPV vaccination is most effective when administered before exposure to the virus. However, eligible individuals may still benefit from vaccination later, according to local recommendations.
Why are the other options incorrect?
- A. Zoster: Protects against shingles caused by reactivation of the varicella-zoster virus.
- B. Varicella: Protects against chickenpox.
- D. Tetanus, diphtheria, pertussis (Tdap): Protects against tetanus, diphtheria, and whooping cough.
Exam pearl: HPV vaccination prevents most HPV-related cervical cancers, but vaccinated individuals should still follow recommended cervical cancer screening guidelines.
Which of the following anticonvulsants needs serum level monitoring for optimize safety and efficacy?
A. Phenytoin B. Locosamide C. Topiramate D. Levetiracetam
Correct Answer: A. Phenytoin
Explanation:
Phenytoin: It is a classic first-generation antiepileptic drug (AED) that requires routine Therapeutic Drug Monitoring (TDM). Phenytoin exhibits nonlinear (zero-order) saturation kinetics at therapeutic doses. Small changes in dose can lead to disproportionately large increases in serum drug concentration, resulting in either treatment failure (subtherapeutic level) or severe toxicity (supratherapeutic level). Furthermore, it is highly bound to plasma proteins (albumin), requiring serum level monitoring to optimize safety and efficacy.
- Total therapeutic range: 10–20 mcg/mL
- Free therapeutic range: 1–2 mcg/mL
Monitoring is particularly important in patients with hypoalbuminemia, renal impairment, or suspected toxicity. In these situations, measuring the free phenytoin concentration may be more informative than measuring the total concentration.
Why are the other options incorrect?
- B. Lacosamide: Routine serum-level monitoring is generally unnecessary.
- C. Topiramate: Routine serum-level monitoring is not usually required; clinical response and adverse effects guide dosing.
- D. Levetiracetam: Routine serum-level monitoring is generally unnecessary because of its predictable pharmacokinetics, although levels may be useful in selected situations.
Exam pearl: Phenytoin is a classic drug requiring TDM because of its narrow therapeutic index and nonlinear pharmacokinetics.
A 60-year-old man presents with complain of chest pain twice weekly. History revealed, chronic stable angina with hypertension and is on atenolol 100 mg daily.
Blood Pressure 147/93 mmHg
Heart rate 65/min
What is the best management?
A. Add lisinopril 20 mg daily
B. Add amlodipine 5 mg daily
C. Diltiazem 30 mg every 8 hours
D. Add isosorbide dinitrate 20 mg twice daily
The correct answer is B. Add amlodipine 5 mg daily.
Explanation:
Clinical Goal: The patient has chronic stable angina accompanied by hypertension (BP 147/93 mmHg) that is not at target, despite being on a maximum/high dose of a beta-blocker (atenolol 100 mg daily). His heart rate is 65 bpm, which means he has room for safe blood pressure and antianginal optimization without causing severe bradycardia.
Why Amlodipine (B): Dihydropyridine calcium channel blockers (like amlodipine) are standard guideline-recommended add-on therapies for patients with stable angina whose blood pressure or angina symptoms are uncontrolled on a beta-blocker alone. They provide additional blood pressure reduction and coronary vasodilation without stacking negative chronotropic (heart rate-lowering) effects.
Why the other options are incorrect:
A. Add lisinopril 20 mg daily: While ACE inhibitors are great for hypertension, adding a long-acting dihydropyridine CCB like amlodipine is more directly indicated for concurrent control of both refractory angina and hypertension when a beta-blocker is already optimized. (Furthermore, starting lisinopril at 20 mg as an initial add-on dose is too high and risks sudden hypotension).
C. Diltiazem 30 mg every 8 hours: Diltiazem is a non-dihydropyridine CCB that depresses heart rate and contractility. Combining it with a high-dose beta-blocker (atenolol) carries a high risk of compounding side effects, causing severe bradycardia or heart block. (His heart rate is already 65/min).
D. Add isosorbide dinitrate 20 mg twice daily: Long-acting nitrates are used for angina symptom relief, but they do not treat hypertension effectively compared to CCBs, and amlodipine provides superior dual management for both uncontrolled blood pressure and angina symptoms in this clinical scenario.
Exam pearl: In chronic stable angina with persistent symptoms despite a beta-blocker, adding a dihydropyridine calcium channel blocker such as amlodipine is a common strategy, particularly when blood pressure remains elevated.
Which of the following vaccinations needs to be proofed for persons working in a healthcare setting?
A. Tetanus B. Varicella C. Rota virus D. Hepatitis B
Correct Answer: D. Hepatitis B
Explanation:
Healthcare personnel should have documented evidence of hepatitis B vaccination because they may be exposed to infected blood and other potentially infectious body fluids through needlestick injuries or other occupational exposures.
For healthcare workers, documentation generally includes a complete hepatitis B vaccine series and, where recommended, a documented protective anti-HBs antibody level of ≥10 mIU/mL after vaccination.
Why are the other options incorrect?
- A. Tetanus: Vaccination is recommended, with boosters according to the immunization schedule, but it is not the key occupational blood-borne infection protection emphasized in this question.
- B. Varicella: Healthcare workers without evidence of immunity should receive varicella vaccination; it is also an important occupational requirement. While immunity to varicella (chickenpox) is recommended or required by many facilities, Hepatitis B is the classic, standard bloodborne pathogen vaccination mandated across global healthcare infection control guidelines (e.g., CDC/OSHA).
- C. Rotavirus: Primarily an infant vaccine and not routinely indicated for healthcare personnel.
Exam pearl: Hepatitis B vaccination and appropriate documentation of immunity are important for healthcare personnel. However, varicella immunity may also need to be documented, depending on institutional policy and local guidelines.
Disclaimer: This content is intended for educational and exam-preparation purposes only. These pharmacy and clinical MCQs are designed to support students and healthcare professionals preparing for NAPLEX, DHA, MOH, HAAD, PEBC, SPLE, and other pharmacy licensing examinations. The answers and explanations are for learning purposes and should not replace current clinical guidelines, professional judgment, or individualized medical advice. Drug selection, dosing, vaccination requirements, and treatment recommendations may vary according to patient-specific factors and local protocols. Always consult authoritative guidelines and qualified healthcare professionals before making clinical decisions.
0 Comments